Pathophysiologic basis for the use of third-generation cephalosporins
Open Access
- 1 April 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (4) , S3-S11
- https://doi.org/10.1016/0002-9343(90)90321-4
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Evaluation of cefotaxime alone and in combination with desacetylacefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal β-lactamaseDiagnostic Microbiology and Infectious Disease, 1989
- Differentiation of -Lactamase Variants of Staphylococcus aureus by Substrate Hydrolysis ProfilesThe Journal of Infectious Diseases, 1989
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serumAntimicrobial Agents and Chemotherapy, 1987
- In Vitro Antibacterial Effects of CephalosporinsDrugs, 1987
- Classification of CephalosporinsDrugs, 1987
- Changing Mechanisms of Bacterial ResistanceThe American Journal of Medicine, 1984
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1981
- WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUSBiochemical Journal, 1965